Research news

Light-regulated drugs as analgesics

A new study involving scientists from IBEC, IQAC/CSIC and CNRS in France uses light-regulated drugs to alleviate the negative emotions associated with chronic pain.

Chronic pain is pain that lasts more than six months. Its origin can be both physiological and emotional, and it is accompanied by symptoms such as hypersensitivity, anxiety and depressive behavior. It has no cure, treatment is difficult, and current drugs don’t alleviate the symptoms.

Read more…

Other news

80-strong audience at Nano World Cancer Day 2017

Today the IBEC-managed Spanish Nanotechnology Platform, NanoMed Spain, co-hosted the fourth edition of Nano World Cancer Day 2017, a global initiative organized as part of World Cancer Day.

It’s the second year running that the platform has hosted the conference, which took place at Vall d’Hebron Instituto de Oncología (VHIO) and was opened by Josep Tabernero, Director of VHIO, and IBEC/NanoMed Spain’s Josep Samitier, who also gave a talk.

Read more…